(Q44488205)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12821941%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Suppression of ARG kinase activity by STI571 induces cell cycle arrest through up-regulation of CDK inhibitor p18/INK4c (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12821941%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12821941%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Noriko Nishimura

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12821941%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Krittaya Sutheesophon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12821941%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Mitsuru Nakamura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12821941%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Kenji Kishi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12821941%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Keiko Okuda

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12821941%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Yuko Sato

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12821941%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Yasuhiko Kano

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12821941%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12821941%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12821941%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12821941%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12821941%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

4074-4082

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12821941%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206498

5 November 2019

exact match

0 references

cites work

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

Protein tyrosine kinase structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

Transformation of Ba/F3 cells and Rat-1 cells by ETV6/ARG.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

A novel human gene closely related to the abl proto-oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

STI571: targeting BCR-ABL as therapy for CML.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

Achieving efficient delivery of morpholino oligos in cultured cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

ARG tyrosine kinase activity is inhibited by STI571.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

Coupled transcriptional and translational control of cyclin-dependent kinase inhibitor p18INK4c expression during myogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

Inactivation of oncoprotein binding by a single Cys706-to-Tyr substitution in the retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

Signal transduction inhibition: changing paradigms in cancer care

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

Apoptosis during HL-60 cell differentiation is closely related to a G0/G1 cell cycle arrest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

The cyclin-dependent kinase inhibitors p18INK4c and p19INK4d are highly expressed in CD34+ progenitor and acute myeloid leukaemic cells but not in normal differentiated myeloid cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021

Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206498

7 January 2021